skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: LWW Online remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium
Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium
Material Type:
Artigo 		Adicionar ao Meu Espaço

Community-, Healthcare-, and Hospital-Acquired Severe Sepsis Hospitalizations in the University HealthSystem Consortium

Page, David B ; Donnelly, John P ; Wang, Henry E

Critical care medicine, 2015-09, Vol.43 (9), p.1945-1951 [Periódico revisado por pares]

United States: Copyright by by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc

Texto completo disponível

Citações Citado por
2
Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer
Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer

Page, David B. ; Hong, Erin ; Kaur, Lakhvir ; Gauntt, Sarah ; Gedney, Holley ; Hobbs, Evthokia ; Perlewitz, Kelly Shea ; Seino, Amanda ; Topp, Zheng Zhu ; Conlin, Alison Katherine

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.12141-12141 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
3
Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)
Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)

Stanton, Sasha E. ; MacDonald, Lisa Diana ; Mellinger, Staci L. ; Moxon, Nicole ; Kelly, Tracy ; Hirsch, Heather Anne ; Fiset, Stephan ; Young, Kristina Hoot ; Page, David B.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS1119-TPS1119 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)
Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)

Page, David B. ; Collins, Krystle Louise ; Rajamanickam, Venkatesh ; Moxon, Nicole ; Mellinger, Staci L. ; Conlin, Alison Katherine ; Seitz, Robert ; McGregor, Kim ; Nielsen, Tyler J. ; McArthur, Heather L.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1082-1082 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)
NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)

Page, David B. ; Su, Alan ; Moxon, Nicole ; Mellinger, Staci L. ; Kelly, Tracy ; Conlin, Alison Katherine ; Topp, Zheng Zhu ; Newell, Pippa ; Fredrich, Nicole ; Massimino, Kristen P. ; Wu, Yaping ; Redmond, William L ; Aliabadi, Shaghayegh ; Sun, Zhaoyu ; Imatani, James ; Stanton, Sasha E.

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.604-604 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

McArthur, Heather L. ; Leal, Jorge ; Shiao, Stephen Lawrence ; Carter, Meredith ; Basho, Reva K ; Phillips, Michelle ; Chan, David ; Hool, Hugo ; Park, Dorothy J. ; El-Masry, Mary ; McAndrew, Philomena ; Sikaria, Swati ; Spring, Laura ; Bardia, Aditya ; Tighiouart, Mourad ; Dadmanesh, Farnaz ; Giuliano, Armando E. ; Sanchez, Katherine ; Page, David B.

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS634-TPS634 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy
Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy

Page, David B. ; Pucilowska, Joanna ; Berinstein, Neil Lorne ; Egan, James E.

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.7-7 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer

McArthur, Heather L. ; Comen, Elizabeth Anne ; Bryce, Yolanda ; Solomon, Stephen Barnett ; Leal, Jorge Henrique S. ; Abaya, Christina DiLauro ; Martinez, Cristal ; Basho, Reva K ; McAndrew, Philomena ; Larkin, Brigid ; Page, David B. ; Mellinger, Staci L. ; Fredrich, Nicole ; Moxon, Nicole ; Reddy, Sangeetha M. ; Carter, Meredith ; Patil, Sujata ; Dogan, Basak ; Gatti-Mays, Margaret Elena ; Norton, Larry

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS635-TPS635 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial
Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial

McArthur, Heather L. ; Leal, Jorge Henrique S. ; Page, David B. ; Abaya, Christina DiLauro ; Basho, Reva K ; Phillips, Michelle ; Chan, David ; Hool, Hugo ; Park, Dorothy J. ; El-Masry, Mary ; McAndrew, Philomena ; Sikaria, Swati ; Spring, Laura ; Bardia, Aditya ; Tighiouart, Mourad ; Dadmanesh, Farnaz ; Giuliano, Armando E. ; Shiao, Stephen Lawrence

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS624-TPS624 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer

McArthur, Heather L. ; Comen, Elizabeth Anne ; Bryce, Yolanda ; Solomon, Stephen Barnett ; Leal, Jorge Henrique S. ; Abaya, Christina DiLauro ; Martinez, Cristal ; Basho, Reva K ; Park, Dorothy J. ; McAndrew, Philomena ; Larkin, Brigid ; Mills, William ; Page, David B. ; Mellinger, Staci L. ; Fredrich, Nicole ; Moxon, Nicole ; Reddy, Sangeetha M. ; Carter, Meredith ; Patil, Sujata ; Norton, Larry

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS617-TPS617 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (82)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (89)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1997  (7)
  2. 1997Até2004  (6)
  3. 2005Até2010  (21)
  4. 2011Até2016  (23)
  5. Após 2016  (34)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.